ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

462
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
31 May 2016 15:45

Korea Stock Market Monthly Recap #2 - (May 2016)

Our portfolio of top picks were up on average 9.5% in May versus KOSPI which was down 0.5% in the same period.  Our top picks in the Korean...

Logo
178 Views
Share
bearishCelltrion Inc
17 May 2016 10:20

Why Be Optimistic if the Payers Are Cautious?

Recent comments from one of the largest health insurers in the U.S. reinforce our view that management's expectations for Remsima (U.S. name...

Share
14 May 2016 07:55

What's All the Fuss About Quantitative Easing in Korea?

There have been lots of discussions in Korea's media about Korea's version of Quantitative Easing in the past several weeks, especially after...

Logo
178 Views
Share
29 Apr 2016 17:21

Korea Stock Market Monthly Recap #1 - (April 2016)

This is the first Korea Stock Market Monthly Recap, which we will attempt to publish on a monthly basis. The purpose our monthly recap are as...

Logo
241 Views
Share
22 Apr 2016 10:10

How Korea National Pension Fund Is Exerting Pressure on Companies to Raise Dividends

Korea National Pension Fund (KNPF), the third largest pension fund in the world, has been exerting more pressure on Korean companies to raise their...

Logo
208 Views
Share
x